Overview
Explain incretin biology and receptor signaling in diabetes and obesity, Differentiate the mechanisms of GLP-1, GIP, and dual agonist therapies, Analyze multi-organ metabolic effects beyond pancreatic regulation, Evaluate clinical data and therapeutic applications of GLP-1–based drugs
Biotech and pharmaceutical researchers developing metabolic therapies., Pharmacy, medical, and life science students seeking therapeutic insights., Clinicians and pharmacists interested in GLP-1–based treatment strategies., Healthcare and biotech professionals curious about obesity and diabetes drug innovation.
No prior knowledge required
GLP-1 receptor agonists and dual GIP/GLP-1 agonists have transformed the treatment of type 2 diabetes, obesity, and cardiometabolic disorders.
Drugs like Ozempic, Wegovy, and Mounjaro are no longer just glucose-lowering agents; they are reshaping obesity management, cardiovascular risk reduction, and even liver disease therapy.
This course is about GLP-1 & GIP Drugs like Ozempic, Wegovy, and Mounjaro used in Obesity & Diabetes Therapy, and is designed to give you a complete, mechanism-driven understanding of how incretin hormones work, why their biology is so powerful, and how modern therapeutics harness these pathways to benefit the people in need.
You will explore the molecular mechanisms of incretin receptors, pancreatic regulation, and multi-organ effects, and then connect this knowledge to real-world therapeutic applications.
Whether you are in biotech research, pharmacy, medicine, or academia, this course bridges cutting-edge molecular biology with practical pharmacology and clinical insight.
By the end, you’ll be able to:
Explain the physiology of GLP-1 and GIP and their complementary roles in glucose regulation
Understand how receptor signaling differences translate into therapeutic outcomes
Evaluate how incretin therapies impact multiple organs: brain, gut, adipose tissue, and liver
Analyze clinical trial data on HbA1c reduction, weight loss, and cardiovascular protection
Appreciate the evolution from GLP-1 analogues to dual agonists, and where the field is going
Dr. Amogh Gopinathan Nair
Dr. Amogh Gopinathan Nair, Ph.D
Immuno-Oncology & Stem Cell Scientist | Antibody Engineering & AI-Driven Drug Discovery | Regulatory Affairs & Translational Research Expert | 15+ Years in Academia & Industry | Merck-MITACS and Lonza-Trained
Hello everyone, I am Dr. Amogh Nair, a scientist-educator with over 15 years of experience at the intersection of cutting-edge biology and real-world drug development—from discovery to IND-enabling studies, clinical trial design, and early market access. Trained in both academic rigor and industry precision, I specialize in therapeutic antibody engineering, immuno-oncology, stem cell technologies, AI-enhanced drug discovery, and regulatory strategy.
My professional journey has taken me from GMP-driven cell line development at Lonza to CRISPR-edited iPSC models at the University of Sheffield, and from multi-specific antibody development in clinical-stage oncology programs to regulatory interactions with global health authorities.
Areas of Expertise:
Antibody Engineering (hybridoma, bi-specifics, ADCs, CAR-T)
Stem Cells & Organoids (hESCs, iPSCs, CRISPR/TALEN, disease modeling)
Immuno-Oncology (tumor biology, MOA studies, biomarker integration)
AI in Drug Discovery (epitope prediction, HT screening, lead optimization)
Regulatory Affairs (preclinical strategy, IND packages, trial design, market access)
As Your Instructor, I Offer:
Clarity & Context – I break down complex topics into actionable insights for biotech, clinical, and regulatory learners.
Real-World Relevance – Every concept connects to current therapeutics, real drug programs, and actual regulatory decisions.
Career-Ready Knowledge – Whether you are transitioning from academia or upskilling in biotech, I teach with the mindset of industry readiness.
Featured Course Topics:
Antibody Engineering for Oncology and Cardio-metabolic diseases (GLP-1, GIP, GCGR) – structure, function, platforms, clinical relevance
CAR-T & Biologics – core concepts, applications, safety, and scalability
AI & Drug Discovery – predictive tools, pipeline acceleration, integration with wet-lab research
Stem Cell Biology in Medicine – iPSC technologies, Organoids, “clinical trials in a dish” and AI integration.
Regulatory Pathways – how therapeutics move from bench to bedside
Outside the lab, I am a dedicated trail runner and culinary explorer—both of which teach the same lesson I bring into the classroom: exploration, precision, patience, and purpose.
If you are seeking an instructor who brings deep scientific knowledge, cross-functional experience, and a passion for clear, impactful teaching, you are in the right place.
Go ahead, learn the skills and explore.